Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Dec-31-07 | Dec-31-06 | Dec-31-05 | Dec-31-04 | Dec-31-03 | Dec-31-02 | Dec-31-01 | Dec-31-00 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Women's Health | | | | | | | 104.2 | 109.7 |
| Women's and Children's Health | | | | | | 98.2 | | |
| Health Enhancement | | | | | | 114.5 | 159.9 | 116.1 |
| Total revenues | 352.2 | 336.1 | 179.2 | 145.1 | 123.2 | 212.6 | 264.0 | 225.8 |
| Revenue growth [+] | 4.8% | 87.5% | 23.5% | 17.8% | -42.1% | -19.5% | 16.9% | |
| Women's Health | | | | | | | -5.0% | |
| Health Enhancement | | | | | | -28.4% | 37.8% | |
| Cost of goods sold | 107.5 | 109.9 | 73.0 | 64.9 | 57.3 | 125.2 | 145.7 | 116.2 |
| Gross profit | 244.7 | 226.2 | 106.3 | 80.1 | 65.9 | 87.4 | 118.3 | 109.6 |
| Gross margin | 69.5% | 67.3% | 59.3% | 55.2% | 53.5% | 41.1% | 44.8% | 48.5% |
| Selling, general and administrative | 174.6 | 159.0 | 94.3 | 79.3 | 64.3 | 70.3 | 76.2 | 68.5 |
| Other operating expenses | 12.4 | 11.2 | 3.9 | 2.4 | 3.4 | 19.8 | 17.4 | 16.8 |
| EBITDA [+] | 79.3 | 76.7 | 14.8 | 4.0 | 3.2 | 3.6 | 39.8 | 38.3 |
| EBITDA growth | 3.4% | 419.6% | 271.7% | 23.0% | -9.1% | -91.1% | 4.1% | |
| EBITDA margin | 22.5% | 22.8% | 8.2% | 2.7% | 2.6% | 1.7% | 15.1% | 16.9% |
| Depreciation | 14.5 | 13.6 | 6.3 | 5.5 | 5.0 | 6.2 | 5.4 | 4.2 |
| EBITA | 64.8 | 63.1 | 8.5 | -1.6 | -1.8 | -2.7 | 34.5 | 34.1 |
| EBITA margin | 18.4% | 18.8% | 4.7% | -1.1% | -1.4% | -1.3% | 13.1% | 15.1% |
| Amortization of intangibles | 7.1 | 7.1 | 0.4 | | | | 9.8 | 9.8 |
| EBIT [+] | 57.7 | 56.0 | 8.1 | -1.6 | -1.8 | -2.7 | 24.6 | 24.3 |
| EBIT growth | 3.1% | 590.0% | -615.9% | -11.9% | -33.1% | -110.8% | 1.5% | |
| EBIT margin | 16.4% | 16.6% | 4.5% | -1.1% | -1.4% | -1.3% | 9.3% | 10.8% |
| Non-recurring items | | | | | | | | 1.6 |
| Interest expense, net [+] | 22.3 | 26.0 | 1.6 | 9.6 | 13.5 | 13.6 | 10.0 | 8.2 |
| Interest expense | 23.9 | 27.6 | 2.4 | 10.1 | 13.7 | 14.0 | 10.4 | 8.6 |
| Interest income | 1.6 | 1.5 | 0.8 | 0.5 | 0.2 | 0.4 | 0.4 | 0.4 |
| Other income (expense), net | 0.2 | 1.3 | 0.2 | -22.2 | 1.4 | -3.2 | -0.6 | 8.3 |
| Pre-tax income | 35.6 | 31.2 | 6.7 | -33.4 | -13.9 | -19.5 | 14.0 | 22.8 |
| Income taxes | 14.5 | 12.8 | 2.7 | -13.3 | -5.4 | -4.4 | 6.1 | 9.1 |
| Tax rate | 40.8% | 40.9% | 40.5% | 39.9% | 39.0% | 22.7% | 43.4% | 39.9% |
| Earnings from continuing ops | 21.1 | 18.5 | 4.0 | -20.1 | -8.5 | -15.0 | 6.8 | 10.1 |
| Earnings from discontinued ops | 0.4 | 34.2 | 9.9 | 47.1 | 15.8 | -0.7 | -1.2 | |
| Net income | 21.4 | 52.7 | 14.0 | 27.1 | 7.3 | -15.8 | 5.6 | 10.1 |
| Net margin | 6.1% | 15.7% | 7.8% | 18.7% | 5.9% | -7.4% | 2.1% | 4.5% |
| |
| Basic EPS [+] | $0.99 | $0.88 | $0.21 | ($1,293.62) | ($559.61) | ($1,077.06) | $0.78 | $1,100.01 |
| Growth | 12.2% | 311.4% | -100.0% | 131.2% | -48.0% | -138639.6% | -99.9% | |
| Diluted EPS [+] | $0.96 | $0.85 | $0.20 | ($1,293.62) | ($559.61) | ($1,077.06) | $0.76 | $1,010.76 |
| Growth | 13.0% | 322.2% | -100.0% | 131.2% | -48.0% | -142503.8% | -99.9% | |
| |
| Shares outstanding (basic) [+] | 21.4 | 21.0 | 18.8 | 0.0 | 0.0 | 0.0 | 8.7 | 0.0 |
| Growth | 1.6% | 11.9% | 121001.8% | 2.1% | 8.8% | -99.8% | 95621.6% | |
| Shares outstanding (diluted) [+] | 21.9 | 21.7 | 19.9 | 0.0 | 0.0 | 0.0 | 9.0 | 0.0 |
| Growth | 0.9% | 9.0% | 127954.1% | 2.1% | 8.8% | -99.8% | 90308.2% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|